Kukje Pharma Co., Ltd. (KRX:002720)

Kukje Pharma Revenue

Kukje Pharma had revenue of 43.98B KRW in the quarter ending March 31, 2026, with 5.96% growth. This brings the company's revenue in the last twelve months to 177.97B, up 10.93% year-over-year. In the year 2025, Kukje Pharma had annual revenue of 175.50B with 12.16% growth.

• Revenue (ttm): 177.97B
• Revenue Growth: +10.93%
• P/S Ratio: 0.41
• Revenue / Employee: 717.63M
• Employees: 248
• Market Cap: 72.80B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	175.50B	19.03B	12.16%
Dec 31, 2024	156.46B	21.09B	15.58%
Dec 31, 2023	135.37B	8.79B	6.94%
Dec 31, 2022	126.58B	6.84B	5.71%
Dec 31, 2021	119.75B	-10.65B	-8.17%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error